{"name":"PhaseBio Pharmaceuticals","permalink":"phasebio-pharmaceuticals","crunchbase_url":"http://www.crunchbase.com/company/phasebio-pharmaceuticals","homepage_url":"http://www.phasebio.com/","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":2002,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"","alias_list":"","email_address":"","phone_number":"610-981-6500","description":"","created_at":"Fri Jan 08 04:35:44 UTC 2010","updated_at":"Wed Jun 06 02:19:20 UTC 2012","overview":"<p>PhaseBio Pharmaceuticals, Inc., a development stage biopharmaceutical company, engages in the generation of biopharmaceuticals. It offers elastin-like peptides (ELP) technology for drug delivery; and deltaPhase, purification technology. Its technology is based on biopolymers of elastin-like repeating subunits to which drugs are attached or peptides and proteins genetically fused enhancing the pharmacology and delivery of therapeutics. PhaseBio Pharmaceuticals, Inc. was formerly known as Phase Bioscience, Inc. and it changed its name in November 2008. The company was founded in 2002 and is based in Morrisville, North Carolina.</p>","image":{"available_sizes":[[[150,49],"assets/images/resized/0007/2629/72629v1-max-150x150.jpg"],[[193,64],"assets/images/resized/0007/2629/72629v1-max-250x250.jpg"],[[193,64],"assets/images/resized/0007/2629/72629v1-max-450x450.jpg"]],"attribution":null},"products":[],"relationships":[{"is_past":false,"title":"CEO","person":{"first_name":"Christopher","last_name":"Prior","permalink":"christopher-prior","image":null}},{"is_past":false,"title":"CFO","person":{"first_name":"Joel","last_name":"Sussman","permalink":"joel-sussman-2","image":null}},{"is_past":false,"title":"Executive Chairman","person":{"first_name":"Craig","last_name":"A. Rosen","permalink":"craig-a-rosen","image":null}},{"is_past":true,"title":"CFO","person":{"first_name":"Thomas","last_name":"Laundon","permalink":"thomas-laundon","image":null}}],"competitions":[],"providerships":[],"total_money_raised":"$54.6M","funding_rounds":[{"round_code":"b","source_url":"http://www.finsmes.com/2010/01/phasebio-pharmaceuticals-raises.html","source_description":"PhaseBio Pharmaceuticals Raises $25M in Series B Funding Round","raised_amount":25000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":1,"funded_day":7,"investments":[{"company":null,"financial_org":{"name":"New Enterprise Associates","permalink":"new-enterprise-associates","image":{"available_sizes":[[[150,110],"assets/images/resized/0001/5083/15083v3-max-150x150.png"],[[150,110],"assets/images/resized/0001/5083/15083v3-max-250x250.png"],[[150,110],"assets/images/resized/0001/5083/15083v3-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"OSI Pharmaceuticals","permalink":"osi-investment-management","image":{"available_sizes":[[[150,16],"assets/images/resized/0007/3195/73195v1-max-150x150.png"],[[250,26],"assets/images/resized/0007/3195/73195v1-max-250x250.png"],[[289,31],"assets/images/resized/0007/3195/73195v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Hatteras Venture Partners","permalink":"hatteras-venture-partners","image":{"available_sizes":[[[150,39],"assets/images/resized/0004/6917/46917v2-max-150x150.png"],[[250,65],"assets/images/resized/0004/6917/46917v2-max-250x250.png"],[[393,103],"assets/images/resized/0004/6917/46917v2-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Johnson & Johnson Development","permalink":"johnson-johnson-development","image":{"available_sizes":[[[150,61],"assets/images/resized/0003/2806/32806v1-max-150x150.png"],[[206,85],"assets/images/resized/0003/2806/32806v1-max-250x250.png"],[[206,85],"assets/images/resized/0003/2806/32806v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Fletcher Spaght Ventures","permalink":"fletcher-spaght-ventures","image":{"available_sizes":[[[150,38],"assets/images/resized/0010/2158/102158v1-max-150x150.png"],[[250,64],"assets/images/resized/0010/2158/102158v1-max-250x250.png"],[[278,72],"assets/images/resized/0010/2158/102158v1-max-450x450.png"]],"attribution":null}},"person":null}]},{"round_code":"b","source_url":"http://olv.duke.edu/About/News/20071025085536830","source_description":"Phase Bioscience raises $6.6 million","raised_amount":6600000,"raised_currency_code":"USD","funded_year":2007,"funded_month":10,"funded_day":24,"investments":[{"company":null,"financial_org":{"name":"Fletcher Spaght Ventures","permalink":"fletcher-spaght-ventures","image":{"available_sizes":[[[150,38],"assets/images/resized/0010/2158/102158v1-max-150x150.png"],[[250,64],"assets/images/resized/0010/2158/102158v1-max-250x250.png"],[[278,72],"assets/images/resized/0010/2158/102158v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Johnson & Johnson Development","permalink":"johnson-johnson-development","image":{"available_sizes":[[[150,61],"assets/images/resized/0003/2806/32806v1-max-150x150.png"],[[206,85],"assets/images/resized/0003/2806/32806v1-max-250x250.png"],[[206,85],"assets/images/resized/0003/2806/32806v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Hatteras Venture Partners","permalink":"hatteras-venture-partners","image":{"available_sizes":[[[150,39],"assets/images/resized/0004/6917/46917v2-max-150x150.png"],[[250,65],"assets/images/resized/0004/6917/46917v2-max-250x250.png"],[[393,103],"assets/images/resized/0004/6917/46917v2-max-450x450.png"]],"attribution":null}},"person":null}]},{"round_code":"b","source_url":"http://pevc.dowjones.com/article?an=DJFVW00020120605e865tt70p&from=alert&pid=32&ReturnUrl=http%3a%2f%2fpevc.dowjones.com%3a80%2farticle%3fan%3dDJFVW00020120605e865tt70p%26from%3dalert%26pid%3d32","source_description":"PhaseBio Pharmaceuticals Books $23M in Third Tranche of Series B ","raised_amount":23000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":6,"funded_day":5,"investments":[{"company":null,"financial_org":{"name":"New Enterprise Associates","permalink":"new-enterprise-associates","image":{"available_sizes":[[[150,110],"assets/images/resized/0001/5083/15083v3-max-150x150.png"],[[150,110],"assets/images/resized/0001/5083/15083v3-max-250x250.png"],[[150,110],"assets/images/resized/0001/5083/15083v3-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Astellas Venture Management","permalink":"astellas-venture-management","image":{"available_sizes":[[[150,23],"assets/images/resized/0004/6637/46637v1-max-150x150.png"],[[250,39],"assets/images/resized/0004/6637/46637v1-max-250x250.png"],[[450,71],"assets/images/resized/0004/6637/46637v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Fletcher Spaght Ventures","permalink":"fletcher-spaght-ventures","image":{"available_sizes":[[[150,38],"assets/images/resized/0010/2158/102158v1-max-150x150.png"],[[250,64],"assets/images/resized/0010/2158/102158v1-max-250x250.png"],[[278,72],"assets/images/resized/0010/2158/102158v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Hatteras Venture Partners","permalink":"hatteras-venture-partners","image":{"available_sizes":[[[150,39],"assets/images/resized/0004/6917/46917v2-max-150x150.png"],[[250,65],"assets/images/resized/0004/6917/46917v2-max-250x250.png"],[[393,103],"assets/images/resized/0004/6917/46917v2-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Johnson & Johnson Development Corporation","permalink":"johnson-johnson-development-corporation","image":{"available_sizes":[[[150,57],"assets/images/resized/0005/8402/58402v1-max-150x150.png"],[[225,86],"assets/images/resized/0005/8402/58402v1-max-250x250.png"],[[225,86],"assets/images/resized/0005/8402/58402v1-max-450x450.png"]],"attribution":null}},"person":null}]}],"investments":[],"acquisition":null,"acquisitions":[],"offices":[{"description":"","address1":"1 Great Valley Parkway","address2":"Suite 30","zip_code":"19355","city":"Malvern","state_code":"PA","country_code":"USA","latitude":null,"longitude":null}],"milestones":[],"ipo":null,"video_embeds":[],"screenshots":[{"available_sizes":[[[150,82],"assets/images/resized/0007/2628/72628v1-max-150x150.jpg"],[[250,137],"assets/images/resized/0007/2628/72628v1-max-250x250.jpg"],[[450,246],"assets/images/resized/0007/2628/72628v1-max-450x450.jpg"]],"attribution":null}],"external_links":[]}